BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  FDA

  Takeda Racks Up Designations for Rare Lung Cancer Drug

  The FDA awarded a number of designations for Takeda’s candidate drug EXKIVITY in the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer.

  September 16, 2021

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  FDA

  COVID-19 Update: Vaccines for Kids and an Upcoming Verdict on Boosters

  FDA external advisors will meet to consider Pfizer and BioNTech data in support of booster shots. The two companies also expect to file for Vaccine Authorization for children in the coming months.

  September 16, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Diseases Gets More Support

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  September 16, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Deals

  Medtech Start-Up Becomes Nasdaq’s First Hong Kong Unicorn

  Hong Kong-based Prenetics Group Limited, a medical diagnostic startup, is making its debut on the Nasdaq through a merger with Artisan Acquisitions Corp. The deal is valued at $1.25 billion.

  September 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Elizabeth Holmes Trial: Whistleblower Testifies to “Frequent” Data Manipulation

  Erika Cheung testified that the data manipulation happened “frequently,” in order to make the company’s lead asset look good to investors.

  September 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Biogen’s Non-Opioid Pain Drug Shines in Small Fiber Neuropathy Study

  The company indicates that the overall data from the vixotrigine program will help them determine dose levels for future Phase III trials.

  September 16, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Approves First Human Trial for Potential CRISPR-Led HIV Cure

  The FDA’s IND approval sets the stage for the very first Phase I/II trial to evaluate EBT-101 as a functional cure for chronic HIV based on the endpoints of safety, tolerability, and efficacy.

  September 16, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Alpine, Anjarium and Amolyt Net New Funds on Lucrative Investment Day

  The proceeds will be used for the companies’ growth, to help develop their platforms and advance their pipelines.

  September 16, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Career Advice

  4 Reasons People Will Change Their Jobs Post-Pandemic

  According to Bloomberg, the Work Trend Index showed that 41% of the survey’s 30,000 respondents planned on leaving their current job.

  September 16, 2021

   · 

  2 min read

   · 

  Brandi Marcene
• 

  Business

  AbCellera Lands Hottest Fishing Partner Yet in Moderna

  Moderna will leverage AbCellera’s AI-powered technology to search and analyze natural immune responses in the hopes of identifying antibodies for up to six targets.

  September 16, 2021

   · 

  2 min read

   · 

  Heather McKenzie